TL;DR
Apple chose Google's $20B/year Safari rent over building its own search engine, which meant skipping the data and ML muscle that an AI health coach now requires. The band gap in 2026 is the same gap as the Siri/Apple Intelligence delay (conversational Siri pushed to 2027) and the downscoping of Health+ to a video subscription.
The band/ring category is real and accelerating. Oura: $11B valuation, ~$1B 2025 revenue, IPO filed. Whoop: $10.1B valuation, $1.1B ARR, $440 ARPU. Google's Fitbit Air at $99 just set the floor. Smart rings are a 22-29% CAGR segment inside a wearable health TAM of $76–168B by 2030.
Long-the-focused-health-pure-plays (Oura, Whoop, Garmin) and Google's Fitbit-as-Trojan-horse; Apple is not a short, but it's short optionality, hence losing the upside (no Ring, no AI coach) while DOJ remedies erode the downside protection of guaranteed Google search rents.
Introduction
Last week, Google introduced Fitbit Air, thereby proving that this is a growing category. So the real question is: “Has Apple missed this form factor? And, if Yes, why?|”
Apple’s perceived “miss” in the health band/ring form factor is not, primarily, a 2026 product decision. It is the second-order effect of a much older capital allocation decision. From the mid-2010s onward, Apple chose to take Google’s search rents in Safari (now ~$20B/year) rather than build its own search-and-data engine. That choice was rational on a discounted cash-flow basis at the time, but it starved Apple of the one capability that compounds the most in 2026 (= large-scale, behavior-level data infrastructure and the ML organization that lives on top of it). That gap is now visible in three places simultaneously:
(1) the Siri/Apple Intelligence delay, with a fully conversational Siri pushed to 2027;
(2) the quiet downscoping of “Health+” (codename Quartz) from an AI health coach to a video subscription; and
(3) the absence of an Apple band or ring at a moment when Whoop has hit a $10.1B valuation, Oura has hit $11B and filed for IPO, and Google has shipped the Fitbit Air at $99.
The market opportunity Apple is ceding is large and accelerating. Wearable medical devices alone are projected to grow from roughly $45-48B in 2025 to between $76B and $168B by 2030, depending on the definition.
Smart rings, the smallest sub-segment, are forecast to grow at 22–29% CAGR. The strategic rerating risk for Apple is that the highest-margin layer of consumer health, namely interpretation (“should I push, rest, sleep, recover?”), gets owned by Oura, Whoop, and Google, while Apple is left selling premium hardware into a maturing watch category.
This is bullish for the focused health-wearable pure-plays (Oura pre-IPO, Whoop, Garmin), constructive for Google’s health stack via Fitbit, and a slow-moving margin and narrative risk for Apple’s Wearables, Home & Accessories segment, which was already down on a like-for-like basis in 2025.
1. The 2016 decision: why this is not really about a band
Apple did not wake up in 2026 having forgotten how to design a wearable. Apple has the silicon, the sensors, the distribution, and the privacy brand. What Apple does not have, at the scale required, is an operational data and machine learning engine. To understand why, the most useful frame is the search engine decision.
Apple has had every ingredient to build a Google-class search engine for a decade. It owns Safari, Spotlight, the App Store search box, Siri, the Maps stack, and a relationship with every iPhone user. Internally, Apple has had a search project (publicly traced through “Applebot” crawling since 2014-15 and later through the “Pegasus” semantic search work led by John Giannandrea after 2018).
The strategic question that mattered, however, was not technical. It was “do we monetize intent ourselves, or do we rent our default to Google?”. Apple chose to rent. Court documents from the DOJ’s antitrust case against Google show Google paying Apple in the order of $20B annually to remain the default search engine in Safari, with Apple receiving roughly 36% of Safari search ad revenue. Eddy Cue testified in 2023 that the deal was “best for consumers” because there was “no valid alternative”, a defensible argument for users, and a perfect argument for not building the alternative. The hidden cost of that decision was never the foregone search ad revenue. It was the foregone data and ML organization. A serious search engine forces a company to:
Build a planetary-scale web and behavior crawling and storage
Build ranking, retrieval, and recommendation models trained on user feedback at billions of events per day
Build an ad auction, which is the single best feedback loop ever invented for ML systems
Hire and retain the kind of ML/infra talent that wants to work on problems at that scale
Apple bought none of that infrastructure muscle because it was getting paid not to. That is the throughline to the band.
2. The compounding gap: from search rent to AI deficit
By 2024-2025, the cost of that 2016-era trade-off became visible. Apple announced Apple Intelligence at WWDC 2024 alongside the iPhone 16, promising a re-architected, conversational Siri that could orchestrate apps and personal context. Across 2025, that timeline slipped repeatedly. By early 2026, Bloomberg and others were reporting that a genuinely conversational Siri would not ship before 2027, and that Apple was actively considering using OpenAI or Anthropic models to power Siri rather than its own.
Three structural problems are visible:
Apple’s foundation models are smaller and less capable than the frontier, in part because Apple does not have a comparable scale of conversational/behavioral training data.
Apple’s on-device privacy posture, while a brand asset, makes the data flywheel harder, not easier, in the absence of a parallel large-scale cloud data operation.
Apple has had to publicly admit that the next generation Siri will likely lean on third-party LLMs, the same dynamic as Safari/Google search, only now in the AI layer.
If you accept the premise that the next decade of consumer health is not about more sensors but about interpretation, “given everything we know about you, what should you do today?”, then this is the same capability gap, manifesting in a different product. A health band that just collects HRV, SpO2, and temperature is a commodity sensor. A health band that tells you, every morning, whether to push or rest is an AI product. Apple is short the AI muscle, not the sensor muscle.
3. The band moment: what Apple is actually missing
Mark Gurman’s recent Bloomberg framing captured the tactical version of the problem: the Apple Watch is over a decade old, the market is fragmenting toward focused, often screenless devices, and Apple’s response so far is incremental.
The strategic version is sharper. Whoop, Oura, and Fitbit Air are not competing with Apple Watch on features. They are competing on job-to-be-done:
Whoop: “I am for recovery, strain, sleep, and performance”.
Oura: “I am for sleep, readiness, temperature, and longitudinal body signals”.
Fitbit Air: “I am a $99 screenless tracker that disappears”.
Apple Watch: “I can do everything, including telling you that your Uber is arriving while you are trying to sleep”.
The key product insight is that health is the first major consumer category where the screen is a liability, not an asset. A device that earns the right to disappear is more trusted, more passively worn, more longitudinally accurate, and crucially, more able to deliver a single daily recommendation rather than a thousand notifications.
Apple’s entire design language for the Watch is about reclaiming wrist attention. The band category is about giving it back. Apple’s response so far is hesitant. The Apple Ring has been rumored since 2019 and reportedly remains an internal project but not an active program (per Gurman, October 2024). Apple’s Health+ / Quartz subscription was downscaled in early 2026 from a full AI coaching service to an educational video product, reportedly due to a combination of leadership turnover (Eddy Cue taking over from Jeff Williams), FDA caution, and AI reliability concerns.
4. Market sizing: TAM / SAM / SOM
4.1 Total Addressable Market (TAM)
TAM, defined as global digital health (wearables, software, telehealth, AI-driven health services combined), is the most generous frame for an Apple-class platform play.
Triangulating, a defensible TAM view for AI-enabled health wearables (the right slice for a Whoop / Oura / Apple band investor lens) is $50B in 2025 growing to $100–170B by 2030, depending on whether software-as-medical-device and platform/subscription revenues are bundled in. Above that sits the broader $570B digital health market, which Apple has the platform leverage to address but is increasingly less positioned to lead.
4.2 Serviceable Addressable Market (SAM)
SAM, defined as the global smart wearables consumer market (smartwatches + smart bands + smart rings), is a tighter frame focused on the device-and-subscription opportunity that maps cleanly to Apple Watch, Whoop, Oura, Fitbit, Garmin and Samsung today.
Working SAM view: the consumer wearable device-plus-subscription opportunity is on the order of $55–-70B in 2026 (smartwatches + bands + rings), growing toward $150–200B by 2030 if you treat smart rings as a high-growth wedge into a larger ambient health category. Within this, the screenless / focused-health segment (where Whoop, Oura, and Fitbit Air live) is the highest-CAGR slice.
4.3 Serviceable Obtainable Market (SOM) for a focused-health band player
For a pure-play health band/ring company today (Whoop, Oura, plausibly an Apple Ring if launched), the realistic obtainable market over a 5-year horizon is constrained more by category penetration than by Apple’s response.
Three reference data points:
Oura is the early benchmark for what “winning a focused-health niche” looks like financially: $1B revenue, 2M paying subscribers, $11B valuation.
Whoop is the benchmark for subscription monetization: ~$440 ARPU on a $1.1B ARR bas, i.e. closer to a SaaS company than a hardware vendor.
Fitbit Air at $99 sets the price floor for ambient bands and re-anchors consumer expectations downward.
Using a conservative 2030 SOM frame, if smart rings are a $5B category by 2030 and screenless bands are an additional $3-5B at retail (excluding subscription), plus subscription revenue layered on top, a realistic ceiling for the focused-health segment is on the order of $12-20B annual revenue by 2030. Compared to today ($3-4B combined), that is a 3-5x category expansion in five years, which is exactly what the public market valuations are now pricing into Oura and Whoop.
5. Growth outlook and category dynamics
Five forces are structurally favorable for the band/ring category through 2030:
Aging demographics in OECD markets, where passive monitoring of cardiovascular health, sleep, and metabolic signals becomes a daily-life category rather than a wellness category.
AI-driven interpretation. The marginal cost of useful, individualized guidance is collapsing. Every player can now layer an LLM coach on top of biometric data; the moat shifts from “do you have the sensor?” to “do you have the data graph and the trust?”.
Subscription economics. Hardware-plus-subscription models (Whoop, Oura) defend better margins than the smartwatch industry has historically achieved on hardware alone.
Regulatory tailwinds (and tail-risks). FDA clearances for AFib detection, blood pressure estimation, and continuous glucose monitoring are pulling consumer wearables into the medical regime, which increases trust and pricing power but raises the barrier for general-purpose smartwatches that aren’t purpose-built for health claims.
Distribution unlocking. Google’s entry at $99 with Fitbit Air, plus Samsung’s bundling of Galaxy Ring with phones, will train mainstream consumers that a band/ring is a normal household device, not a niche product.
6. Conclusion: hardware companies that won’t make their own software
Anyone serious about consumer health hardware in 2026 must own the data and the inference layer, not just the device. Apple chose, almost two decades ago, to be paid for not building that layer. That choice looked like free money for a long time.
The Apple Watch is still a remarkable product, but the next health interface is increasingly likely to be screenless, ambient, subscription-attached, and AI-coached, and the companies that win it will be the ones that have spent the last decade building large-scale, behavior-level data infrastructure. Google has. Whoop has. Oura is building one. Apple, structurally, has not. That is the real shape of the miss. The band is the visible symptom. The 2016 decision is the underlying condition.
WIMM for companies: If you would like to offer the newsletter as a benefit to other employees in your company, please contact me directly. ([email protected])
Work with me: If you are interested in working with me on your personal portfolio, again, contact me. I’m a certified financial consultant.
Finally, “Where is my moat?” is designed for individual readers, though the occasional forward is absolutely fine.
Thanks for your support & have a wonderful day!
